UK markets closed

LAVA Therapeutics N.V. (LVTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.8400-0.1900 (-6.27%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-41,974
-41,974
-31,907
-42,355
-15,927
Depreciation & amortisation
1,278
1,278
781
558
464
Deferred income taxes
-279
-279
-249
-157
-43
Stock-based compensation
5,039
5,039
4,113
3,907
557
Change in working capital
-2,827
-2,827
34,113
10,837
4,730
Accounts receivable
-
-
-
-
-1,068
Accounts payable
334
334
1,413
1,618
323
Other working capital
-39,702
-39,702
3,456
-29,411
-9,809
Net cash provided by operating activities
-38,972
-38,972
4,043
-28,647
-9,307
Cash flows from investing activities
Investments in property, plant and equipment
-730
-730
-587
-764
-502
Purchases of investments
-90,082
-90,082
-70,877
-45,291
0
Sales/maturities of investments
73,177
73,177
80,810
2,510
0
Net cash used for investing activities
-17,635
-17,635
9,346
-43,545
-502
Cash flows from financing activities
Debt repayment
-1,041
-1,041
-343
-340
-240
Common stock issued
0
0
0
94,189
0
Common stock repurchased
0
0
0
-5,167
-4,849
Net cash used provided by (used for) financing activities
-571
-571
283
151,160
18,969
Net change in cash
-57,178
-57,178
13,672
78,968
9,160
Cash at beginning of period
100,333
100,333
90,869
15,818
7,338
Cash at end of period
44,231
44,231
100,333
90,869
15,818
Free cash flow
Operating cash flow
-38,972
-38,972
4,043
-28,647
-9,307
Capital expenditure
-730
-730
-587
-764
-502
Free cash flow
-39,702
-39,702
3,456
-29,411
-9,809